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Leishmania donovani causes visceral leishmaniasis
(VL) where the parasite infects and resides inside
liver and spleen tissue macrophages. Given the
abnormal lipid profile observed in VL patients, we
examined the status of serum lipids in an experi-
mental murine model of VL. The murine VL liver dis-
played altered expression of lipid metabolic genes,
many of which are direct or indirect targets of the
liver-specific microRNA-122. Concomitant reduction
of miR-122 expression was observed in VL liver. High
serum cholesterol caused resistance to L. donovani
infection, while downregulation of miR-122 is
coupled with low serum cholesterol in VL mice.
Exosomes secreted by the infective parasites
caused reduction in miR-122 activity in hepatic cells.
Leishmania surface glycoprotein gp63, a Zn-metallo-
protease, targets pre-miRNA processor Dicer1 to
prevent miRNP formation in L. donovani-interacting
hepatic cells. Conversely, restoration of miR-122 or
Dicer1 levels in VL mouse liver increased serum
cholesterol and reduced liver parasite burden.
INTRODUCTION
Visceral leishmaniasis (VL) is caused by the protozoan parasite
Leishmania donovani or Leishmania infantum and is the most
fatal form of this parasitic disorder (Murray et al., 2005). The
parasite infects the spleen and liver of infected individuals and
resides within the macrophages to escape host immune
response (Olivier et al., 2005) It shows a dimorphic life cycle,
residing as flagellate promastigotes in the midgut of the sand
fly vector and as aflagellate amastigotes in the mammalian
host (Desjardins and Descoteaux, 1998; Engwerda et al.,
2004). Liver is the primary organ that gets infected in the early
phase of infection where the parasites survive within the tissue
macrophage Ku¨pffer cells, while the liver parenchyma remains
noninfected (Beattie et al., 2010).
VL patients show hypolipidemia characterized by reduced
serum total cholesterol and lipoproteins (Lal et al., 2007). Inter-Cell Hoestingly, hyperlipidemia is associated with resistance to VL
(Ghosh et al., 2012). In experimental VL, reduced membrane
cholesterol in infected macrophages leads to increased
membrane fluidity affecting its antigen-presenting ability
(Chakraborty et al., 2005). Liposomal formulation of cholesterol
is known to offer protection in infected hamsters (Banerjee
et al., 2009). Although the involvement of cholesterol in control-
ling VL is evident from these studies, little is known about the
influence of Leishmania on host lipid metabolism.
MicroRNAs (miRNAs), the 20–22 nt long posttranscriptional
regulators, mediate gene repression primarily by inducing
translational repression or degradation of target mRNAs to
affect almost all physiological processes including metabolic
processes in higher eukaryotes (Filipowicz et al., 2008;
Kru¨tzfeldt and Stoffel, 2006). Precursors to miRNAs, primary
miRNA transcripts (pri-miRNAs) are processed by micropro-
cessor Drosha-DGCR8 in the nucleus to generate precursor
miRNAs (pre-miRNAs), which are subsequently processed to
the mature form by RNase III endonuclease Dicer1 in the cyto-
plasm (Filipowicz et al., 2008). The miRNA encoding strand of
miRNA duplex gets loaded to Argonaute proteins by DICER1
and TAR RNA-binding proteins (TRBPs) to form active micro-
RNA ribonucleoprotein complexes (miRNPs). miR-122, a miRNA
expressed abundantly in liver, modulates a wide range of liver
functions. miR-122 comprises more than 70% of the liver
miRNA pool and is largely responsible for liver homeostasis
and lipid metabolism (Chang et al., 2004; Girard et al., 2008).
Antisense oligonucleotides against miR-122 confirmed its role
in fatty acid and cholesterol metabolism (Elme´n et al., 2008;
Esau et al., 2006). Therefore, it is an interesting possibility
that parasite infection controls liver miR-122 in order to modu-
late serum cholesterol.
L. donovani interacts with its target cell either by cell-cell
contact or by secreting exosomes containing virulence factors
(Silverman et al., 2010). The surface metalloprotease gp63, a
membrane-bound glycosylphosphatidylinositol (GPI)-anchored
glycoprotein of 63 kDa, is a known virulence factor present in
Leishmania exosomes that serves as a ligand for the macro-
phage complement receptor (Brittingham et al., 1995). This
Leishmania surface protease cleaves multiple intracellular
proteins and participates in p38 mitogen-activated protein
(MAP) kinase inactivation (Halle´ et al., 2009). gp63 is also respon-
sible for selective degradation of eIF4E in L. donovani-infected
macrophages (Jaramillo et al., 2011).st & Microbe 13, 277–288, March 13, 2013 ª2013 Elsevier Inc. 277
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Figure 1. Reduction in Serum Lipids with
Progress of L. donovani Infection in Mouse
Liver
(A) Level of total serum cholesterol in L. donovani-
infected BALB/c mice. Serum cholesterol levels in
mice infected for 8, 15, 30, or 60 days were
measured and plotted individually.
(B–D) Levels of HDL (B), LDL (C), and triglyceride
(D) in the blood serum of 8, 15, 30, or 60 days of
infected or age-matched normal animals.
(E) Liver parasite load in individual animals from
different experimental groups estimated and
plotted as LDU against infection time.
(F) Level of serum glucose in L. donovani-infected
(1 or 2 months) and normal animals. Data repre-
sent mean ± SEM. For each experiment n = 8.
Significance levels: ns (not significant), p > 0.05,
*p < 0.05, **p < 0.001, ***p < 0.0001. See also
Table S1 and Figure S1.
Cell Host & Microbe
Leishmania donovani Reduces miR-122 in Mouse LiverWe have shown in this study that L. donovani infection
downregulates miR-122 and genes involved in cholesterol
biosynthesis in infected mouse livers to reduce serum choles-
terol. We have also found that restoration of miR-122 induces
revival of serum cholesterol and reduction in liver parasite count.
Leishmania metalloprotease gp63, a component of Leishmania
exosomes, gets internalized to degrade Dicer1 in hepatic
cells. It inhibits Dicer1-mediated pre-miR-122 processing
to restrict miRNP formation and prevents miR-122 activity in
L. donovani-interacting hepatocytes.
RESULTS
L. donovani Alters Serum Lipid Profiles of Infected
Animals
Abnormal lipid profiles identified in VL patients (Ghosh et al.,
2011; Liberopoulos et al., 2002) made us interested to look at
the status of serum lipids in L. donovani-infectedmice. Measure-
ment of total cholesterol showed a gradual lowering in serum278 Cell Host & Microbe 13, 277–288, March 13, 2013 ª2013 Elsevier Inc.cholesterol with almost 50% reduction
at 60 days postinfection (p.i.) in
L.donovani-infected BALB/c mice. Major
serum lipoproteins like high-density lipo-
protein (HDL) and low-density lipoprotein
(LDL) also showed similar trends (Fig-
ures 1A–1C). Serum triglyceride dropped
up to 65% until 30 days p.i. with a partial
recovery at 60 days p.i. (Figure 1D). An
inverse correlation between serum
cholesterol level and parasite load was
evident (Figure 1E and Table S1). Histo-
logical examination of the infected liver
section also revealed a gradual increase
in both number and size of granuloma,
with progress of infection where para-
sites were also visible (Figures S1A and
S1B). Overall, we observed a substantial
difference in serum lipid profiles in
L.donovani-infected animals, whereasserum glucose level remained unaffected (Figure 1F). Similar
changes in serum cholesterol were also documented in L.dono-
vani amastigote-infected mouse livers (Figures S1C and S1D).
Altered Expression of Lipid Metabolic Genes in
Leishmania-Infected Mouse Liver
In order to dissect the cause of these abnormalities in the lipid
profile of L. donovani-infected animals, we checked the expres-
sion levels of lipid metabolic genes in infected mouse liver. A
whole-genome microarray analysis was done using an Illumina
Mouse WG-6 v2 BeadChip gene expression array. Of 45,200
total transcripts analyzed, 9,659 showed a differential expres-
sion (5,501 were downregulated, and 4,148 were upregulated)
with more than or equal to 2-fold changes in their expression in
infected livers (Figure 2A). The whole microarray data have
been uploaded to the Gene Expression Omnibus database
(accession number GSE38985).
Scrutiny of differentially expressed gene clusters revealed that
a large number of genes showing reduced expression in infected
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Figure 2. Altered Expression of Lipid Metabo-
lizing Genes in the Livers of L. donovani-
Infected Animals
(A–C) Whole-genome microarray analysis revealed
differentially expressed genes in L.donovani-infected
liver. A pie chart representation of number of genes
that showed altered expression in mouse livers after
60 days p.i. is shown. RNA was isolated from normal
(n = 3) or infected (n = 2) livers, and whole genome
microarray analysis was done (A). Heatmap of lipid
metabolic genes (B). Fold changes obtained from
both real-time quantification and microarray analysis
were plotted for the key lipid metabolizing genes that
showed either an increased or decreased expression
in infected livers (C).
(D) Decreased expression of cholesterol anabolic
proteins HMGCR or ACAT2 in infected mouse liver.
Liver tissue extracts were western blotted for
HMGCR or ACAT2 detection. b-actin was used as
loading control. n = 4 for noninfected control and
60 days p.i.
(E) Changes in expression of important lipid meta-
bolic genes in infected animal livers with progress of
infection. Respective fold changes in expression
were quantified by real-time PCR. For all real-time
estimations, nR 3. SD was from three independent
measurements. Data represented as ±SEM. See also
Table S2.
Cell Host & Microbe
Leishmania donovani Reduces miR-122 in Mouse Liverlivers are related to lipid metabolism (83 showed more than or
equal to 2-fold changes among 476 genes considered). A heat-
map was generated showing differences in expression of lipid
metabolizing genes between normal (n = 3) and infected (n = 2)
groups (Figure 2B). A list comprising lipid metabolizing genes
with fold change (upregulated or downregulated) greater than
or equal to two are provided as a table (Table S2). In summary,
the gene expression data suggest that a major alteration in lipid
metabolism occurs in L. donovani-infected mouse liver. Among
the genes listed, HMGCR (hydroxyl-3-methylglutaryl coenzyme
A reductase), the rate-limiting enzyme for de novo cholesterolCell Host & Microbe 13, 277–biosynthesis (fold downregulation = 2.9),
and CYP7B1 (25-hydroxycholesterol-
7alpha-hydroxylase), a member of the
monooxygenase cytochrome P450 super-
family that catalyzes the first step of catab-
olism of cholesterol to bile acid (fold upre-
gulation = 12.71), are of key importance in
cholesterol metabolism. The validation of
the microarray data was performed by
real-time quantification of seven (five
showed downregulation and two showed
upregulation in microarray analysis) of
these genes. All of them showed propor-
tional changes in their expression in in-
fected mouse livers (Figure 2C). Changes
in protein levels for HMGCR and ACAT2
were also confirmed by western blot anal-
ysis (Figure 2D). Interestingly, these genes
showed altered expression even during
the early stage of infection when the serum
cholesterol level also starts to decrease(Figure 2E). Themicroarray data suggested an overall downregu-
lation in cholesterol-synthesizing genes and selective upregula-
tion of cholesterol catabolic genes that result in the lowering of
serum cholesterol in Leishmania-infected mice.
Leishmania Infection ReducesmiR-122 Levels in Mouse
Liver
A more detailed analysis of the microarray data highlighted an
interesting finding: several lipid-metabolizing genes showing
differential expression in the livers of infected animals are direct
or indirect targets of miR-122 (Table S3). Among them, HMGCR,288, March 13, 2013 ª2013 Elsevier Inc. 279
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Figure 3. miR-122 Acts as a Modulator of Parasitic Infection in L. donovani-Infected Mouse Liver
(A and B) Downregulation of miR-122 in L. donovani-infected mouse liver. Liver miR-122 levels in L. donovani-infected BALB/c mice were quantified by real-time
quantification. U6 small nuclear RNA (snRNA) was used for normalization. miR-122 content in age-matched noninfected animals were used as reference value (A).
Northern blot to detect miR-122 changes in infected mouse livers (B). Ethidium bromide (EtBr)-stained gel was used for loading control. For real-time quanti-
fication n = 8 for each time point.
(C) Levels of AGO2 and RCK/p54 protein in L. donovani-infected mice. Western blot analysis for AGO2 and RCK/p54 proteins in liver extracts from normal and
infected animals. b-actin was used as loading control.
(D) Changes in expression ofmiR-122 and the serum cholesterol level inmice after introduction of miR-122 expression plasmid pmir122 through tail vein injection.
Animals were sacrificed after indicated time; liver miR-122 and serum cholesterol levels were measured.
(E) A schematic representation of the time course of exogenous miR-122 expression in infected mouse liver. Infection time is marked by a white arrow, and the
black arrow defines the time of sacrifice 30 days p.i. The black arrowheads mark the injection time of miR-122 expression plasmids.
(F–H) Effect of upregulation of miR-122 on infection level in mouse livers. Infected animals were treated as per the schedule described in (E) and were sacrificed
after a month. Relative miR-122 expression (F), serum cholesterol level (G), and hepatic parasite load (H) were compared in pmiR-122-treated versus sham-
treated groups. Data represent mean ± SEM. For all experiments, n = 8. ***p < 0.0001, **p < 0.001. L.d, L.donovani. See also Table S3 and Figure S2.
Cell Host & Microbe
Leishmania donovani Reduces miR-122 in Mouse Livera rate-determining enzyme in cholesterol biosynthesis (fold
downregulation = 2.9), and FASN (fatty acid synthase), control-
ling fatty acid synthesis (fold downregulation = 2.7), are known
to be reciprocally regulated by miR-122 (Esau et al., 2006).
Connection between miR-122 and lipid metabolism is well
documented in mammals (Girard et al., 2008). Therefore, we280 Cell Host & Microbe 13, 277–288, March 13, 2013 ª2013 Elseviemay expect reduced miR-122 activity in L. donovani-infected
livers. Levels of miR-122 in the total RNA isolated from the
livers of normal and infected animals were determined. Real-
time quantification revealed a gradual downregulation of
miR-122 in mouse livers with progressive infection (Figure 3A).
Northern blot analysis corroborated this finding (Figure 3B). Ar Inc.
Cell Host & Microbe
Leishmania donovani Reduces miR-122 in Mouse Liversimilar decrease in the miR-122 level was also observed in
animals infected with L.donovani amastigotes (Figure S2A).
Reduced miR-122 activity could not be due to lower expres-
sion of miRNP components, as we did not find any reduction
in miRNP-interacting protein RCK/p54 in infected livers (Fig-
ure 3C). Interestingly, AGO2, the key miRNP component,
showed an increased expression in infected liver. Therefore,
L. donovani infection reduces liver miR-122 to control the
serum cholesterol level.
Exogenous Expression of miR-122 Can Rescue Serum
Cholesterol and Clear Hepatic Parasite Load
In order to understand the significance of miR-122 downregula-
tion during the L. donovani infection process, we aimed to
complement the reduced miR-122 level in the livers of infected
animals. To that end, we injected pmir122, amiR-122 expression
plasmid with a constitutive U6 promoter, in noninfected mouse
via tail vein and monitored miR-122 levels in its liver until
7 days postinjection. The miR-122 level was increased and
was at a maximum after 3 days, whereas the serum cholesterol
level started to show changes at 3 days and reached amaximum
at 5 days p.i.(Figure 3D). To highlight the protective role of miR-
122, we injected miR-122 expression plasmid in animals after
15 days p.i. when initial infection was already established.
Animals received three doses of pmir122 injection, and the
parasite load was monitored at 30 days p.i. (Figure 3E). We
documented an increase in miR-122 level with a concomitant
elevation in serum cholesterol (Figures 3F and 3G). This also
induced reversal of expression of key cholesterol metabolic
genes (data not shown). Interestingly, the hepatic parasite load
was reduced significantly compared to sham-treated control
animals (Figure 3H) showing the protective action of miR-122
against L. donovani infection.
L. donovani Interacts with Human Hepatocytes and
Impairs miRNA-Mediated Repression
The in vivo experiments described above confirmed the lowering
of miR-122 in L. donovani-infected mouse liver. In liver,
L. donovani infects the tissue macrophage Ku¨pffer cells, but
how the infection of Ku¨pffer cells induces miR-122 downregula-
tion in hepatocytes is not known. To understand the mechanism
of hepatic miR-122 downregulation in infected animals, we
used human Huh7 hepatoma cells that express miR-122. Huh7
cells were transfected with a Renilla luciferase reporter either
with no miRNA binding sites (RL-con) or with three imperfect
miR-122 binding sites (RL-3xbulge-miR-122; Figure 4A) to
assess the miR-122 activity in Huh7 cells before and after inter-
action with L. donovani.
To imitate the liver microenvironment, we cocultured Huh7
cells (expressing RL reporters) with isolated human peripheral
blood mononuclear cells (PBMC) in the presence and absence
of Leishmania parasites at different cell-to-parasite ratios; the
monocyte in PBMC served as the parasite host and Huh7 cells
as hepatocytes. There was essentially no change in miR-122
activity when Huh7 and PBMC were cultured in the absence of
the parasite (data not shown). For a fixed number of Huh7 cells,
with an increase in PBMC-to-parasite ratio, there was a
moderate change in miR-122-mediated repression in Huh7 cells
(Figure 4C). It is possible that a host secretory factor, probablyCell Hoa pro- or anti-inflammatory cytokine, secreted by the infected
macrophage/monocyte cells changes the hepatic microenvi-
ronment that leads to compromised miR-122 activity. To test
this hypothesis, we cultured Huh7 cells with Leishmania-
infected whole PBMC supernatant. No significant changes
were observed, even at the highest PBMC-to-parasite ratio
(Figure 4B).
From the above experiments it was evident that the parasite
itself is the probable candidate to cause the effect on hepatic
miR-122. In order to ascertain the importance of direct interac-
tion between Huh7 and Leishmania for impairment of miR-122
activity in hepatocytes, we used isolated amastigotes or trans-
formed promastigotes of L. donovani to test their effect, if any,
on miR-122 activity in human hepatoma cells. Huh7 cells were
incubated with L. donovani promastigotes at different cell-to-
parasite ratios for 24 hr. There was a gradual reduction in repres-
sion level with an increasing parasite number per Huh7 cell
(Figure 4D). A similar result was obtained when the amastigote
form of the parasite was used (Figure 4E). Although upon interac-
tion with the parasite no appreciable change in cellular transcrip-
tion machineries was observed, a drastic reduction in protein
translation was evident in L. donovani-treated Huh7with an over-
all decrease in proliferation of L. donovani-interacting Huh7 cells
(Figures S3A–S3C).
Is a parasite-derived secretory factor required for downregula-
tion of miR-122 activity in target cells? Huh7 cells were treated
with cell-free L. donovani culture supernatant grown at 22C,
the temperature of leishmanial growth at the gut of the sandfly
vector. The supernatant could not show any effect on miR-122
activity in Huh7 cells (Figure 4F), but supernatant of the
Leishmania culture grown at 37C, the temperature the parasite
encounters in mammalian hosts, can reduce miR-122 activity in
Huh7 cells (Figure 4F). Thus, Leishmania-free culture media at
37C should contain a factor(s) that can mediate the anti-miR-
122 activity in hepatocytes.
Leishmania Glycoprotein gp63 Is Responsible for
Reversal of miR-122-Mediated Repression in Huh7
Leishmania exosomes, the secretory vesicles released by the
parasite, have been documented previously as the carrier of
the virulence factors for cellular communication. It is also known
that high temperature and low pH increase the rate of exosome
secretion by Leishmania (Silverman et al., 2010). Hence, we
speculate that the exosomes released by the parasites grown
at 37C may contain the key component(s) required for the
lowering of miR-122 activity in Huh7 cells. In order to investigate
this possibility, we purified exosomes from cell-free Leishmania
culture supernatant grown at 37C.
Isolated L. donovani exosomes showed reduced miR-122-
mediated repression, whereas control exosomes isolated
from the culture media kept at 37Cwithout the parasite showed
no difference in miR-122-mediated fold repression compared
to untreated cells (Figures 4G and 4H). Previous exploration of
the Leishmania exosomal cargo proteins revealed that one
of the virulence factors, gp63 (a Zn2+ dependent metallopro-
tease), is an abundant protein in Leishmania exosomes (Silver-
man et al., 2010). Preincubation of Leishmania exosomes with
o-Phenanthroline, a Zn2+ chelator and an inhibitor of Zn2+ metal-
loproteases, had an inhibitory effect on the ability of Leishmaniast & Microbe 13, 277–288, March 13, 2013 ª2013 Elsevier Inc. 281
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Figure 4. Inhibition of miR-122 in Huh7 Cells by L. donovani
(A) Schematic picture of the miR-122 reporter used to measure the miR-122 activity in Huh7 cells. For relative fold repression, the calculation level of repression
for controls was always settled to 1.
(B–E) Modulation of miR-122 activity in Huh7 cells by L.donovani. Huh7 expressing either the RL-con or RL-3 3 bulge-miR-122 Renilla luciferase reporter along
with firefly luciferase encoding control mRNA were grown and treated differently (as described below) before the luciferase activities were measured and relative
fold repression values calculated. (B) Huh7 cultured with Leishmania-infected human PBMC supernatant. (C) Huh7 cocultured with human PBMC and with
increasing numbers of L. donovani parasite. Huh7 cultured with L. donovani promastigotes (1:1, 1:10, 1:100) (D) or amastigotes (1:1, 1:10, 1:100) (E).
(F–J) Exosomes released by L.donovani affects miR-122 activity in Huh7 cells. As described above, Huh7 cells expressing miR-122 reporter or control mRNAs
were treated with L.donovani culture supernatant (grown at either 22C or 37C) or control medium used for parasite growth (M199), and fold repression values
were calculated (F). Exosomes isolated from the L. donovani promastigote-grown (G) or amastigote-grown (H) medium or control medium were also used to test
its effect on miR-122-mediated repression. In similar experiments, L.donovani exosomes either pretreated with the Zn-chelator o-Phenantholine (I) or anti-gp63
antibody (J) were used to score their effect on exosome-dependent inhibition of miRNA-mediated repression. Normal IgG was used as a control. Data represent
mean ± SEM. Significance level, *p < 0.05, **p < 0.001, ***p < 0.0001). Ld, Leishmania donovani. See also Figure S3 and Movie S1.
Cell Host & Microbe
Leishmania donovani Reduces miR-122 in Mouse Liverexosomes to reverse miRNA action in Huh7 cells (Figure 4I). A
rabbit polyclonal antibody raised against L. donovani gp63 was
used to block its activity in vitro (Bhowmick et al., 2008). Exo-
somes preblocked with this anti-gp63 antibody could not282 Cell Host & Microbe 13, 277–288, March 13, 2013 ª2013 Elsevieprevent the miRNA repression, whereas pretreatment with
normal rabbit immunoglobulin G (IgG) failed to reverse the inhib-
itory role of leishmanial exosomes on miR-122 activity in Huh7
cells (Figure 4J). Overall, these experiments suggest that gp63r Inc.
Cell Host & Microbe
Leishmania donovani Reduces miR-122 in Mouse Liverglycoprotein, a Leishmania exosomal component, is responsible
for the anti-miR122 activity observed in Huh7 cells.
Internalization of Leishmania Exosomes Is Essential for
miR-122 Downregulation in Hepatocytes
Entry of L. donovani or parasite-derived exosomes into host cells
is well documented (Silverman et al., 2010). No such direct
evidence is reported for cellular entry of either intact Leishmania
or L. donovani exosomes in liver parenchymal cells. From the
previous experiments it was evident that the exosomes caused
downregulation of miR-122 activity in human hepatoma cells,
but it was not clear whether the internalization of the exosomes
in heptocytes is required or if its interactionwith themembrane of
Huh7 cells is sufficient for lowering miR-122 activity. Immunoflu-
orescence analysis showed internalization of gp63 in Endo-GFP-
expressing Huh7 cells that were treated with L. donovani exo-
somes. In exosome-treated Huh7 cells, the Endo-GFP-tagged
early endosomes were either colocalized or showed proximal
localization with gp63 (Figure S3D). Three-dimensional reconsti-
tution of the z-stacked images obtained with a spinning disc
confocal microscope was used to confirm the colocalization of
the gp63 signal with early endosomes (Figure S3E; Movie S1).
Therefore, the entry pathway of Leishmania gp63 to Huh7 cells
is possibly endosomal. In subsequent experiments with Endo-
GFP-expressing Huh7 cells treated with siRNA against dynamin
2, a GTPase involved in membrane trafficking of vesicles
(Durieux et al., 2010) showed no internalization or co- or proximal
localization of gp63 with Endo-GFP inside the hepatocytes.
GFP-tagged endosomes in cells treated with control siRNA
showed dynamin 2 colocalization with Endo-GFP and gp63
(Figures S3F and S3G). Downregulation of gp63 internalization
in dynamin 2-compromised cells also reduced the effect of exo-
somes on miR-122-mediated repression in Huh7 (Figure S3H).
Do intact parasites internalize inside the hepatocytes? When
incubated with live L. donovani, parasitic nuclear DNA stained
with DAPI and proximally localized with gp63 signals in intact
parasites was absent in Huh7 cells but visible in murine perito-
neal macrophages. This suggests an absence of intracellular
parasites in infected hepatic cells (Figure S4A and S4B).
In infectedmouse liver, immunofluorescence staining for gp63
identified infected regions with elevated gp63 signal that faded
out with distance from the zone of infection. Interestingly, apart
from the intracellular signals of gp63 inside the hepatocytes
surrounding the infected region, strong signals from gp63-
positive vesicles/bodies along the intercellular space between
hepatocytes were evident (Figure S4C).
Accumulation of Pre-miR-122 and Failed miRNP-122
Formation Accounts for the ReducedmiR-122 Activity in
L. donovani-Treated Huh7 Cells
Interestingly, unlike the mature form, the pre-miR-122 increased
in both parasite-infected mouse livers and L. donovani-treated
Huh7. Real-time quantification of pre-miR-122 confirmed accu-
mulation of the precursor form with progressive infection, which
augmented to 3-fold higher than its normal level at 60 days p.i.
(Figure 5A). The pre-miR-122 also increased 2.5-fold in Huh7
cells after its interaction with L. donovani (Figure 5B).
Why should the precursor accumulate in L. donovani-interact-
ing hepatic cells? In eukaryotes, pre-miRNAs are cleaved andCell Hoprocessed by an RNase III enzyme, DICER1. This protein
processes the pre-miRNAs and loads the processed mature
miRNA to AGO proteins to form active miRNPs (Bartel, 2004).
When the AGO2 protein was immunoprecipitated from normal
and infected Huh7 cell lysates, we documented a 6-fold reduc-
tion of miR-122 association with immunoprecipitated AGO2 in
L. donovani-treated Huh7 (Figure 5C). The observation was
similar when miR-16 association with AGO2 was measured
(data not shown). These results signify an impaired processing
of precursor miRNAs as a mechanism that leads to reduced
miRNP formation, which accounts for lowered miRNP activity
in L. donovani-interacting hepatic cells.
gp63 Cleaves DICER1 to Prevent Effective miRNP
Formation and Inhibits miR-122 Activity in Human
Hepatocytes
From the previous experiments it was evident that AGO2 failed
to get loaded with miR-122 and form active miRNP in
L. donovani-exposed hepatic cells. Hence, it was essential to
look at the status of Dicer1 in infected tissue samples. We de-
tected a low level of Dicer1 in infected livers after 60 days p.i.
as well as in Huh7 treated with L. donovani (Figure 5D). Over-
expressed DICER1 in Huh7 cells inhibited the derepression of
miR-122 activity by L. donovani (Figure 5E). Interestingly,
when a miR-122 mimic that does not require the DICER1 pro-
cessing step was transfected in Huh7 cells, the inhibition of
miRNA activity by Leishmania was lost. However, in Huh7 cells
expressing exogenous pre-miR-122 that required DICER1 pro-
cessing to generate miRNP-122, L. donovani-mediated
reversal of miR-122 activity was unaffected (Figure 5F). These
results further confirm Dicer1 as the primary target of
Leishmania to downregulate miR-122 activity in mammalian
liver. We anticipate degradation of DICER1 by a Leishmania-
derived factor in target hepatic cells. We observed that HA-
tagged DICER1 expressed in Huh7 cells was cleaved in the
presence of Leishmania lysate when incubated in vitro
(Figure 5G). The cleavage of DICER1 was primarily by a Zn-
metalloprotease, as the DICER1 degradation was prevented
in the presence of o-Phenanthroline (Figure 5G). This experi-
ment indicates that gp63, the most abundant Zn-metallopro-
tease present in leishmanial exosomes, is responsible for
DICER1 cleavage. That was further tested when purified
gp63 was incubated with DICER1 in an in vitro reaction. Puri-
fied gp63 cleaved DICER1 and generated the same fragments
obtained with the leishmanial extract. A cleaved N-terminal
fragment of 180 kDa was generated along with a shorter
C-terminal half (Figure 5H). The specificity of gp63 in Dicer1
cleavage reaction was further confirmed in experiments in
which blocking with a polyclonal antibody reduced the activity
of purified gp63. Interestingly, the monoclonal antibody treat-
ment augmented the activity of gp63 (Figure 5I), possibly due
to a change in its conformation upon antibody binding as re-
ported earlier for few other enzymes (Benito et al., 1996;
Cooper and King, 1986). DICER1 associates and transfers
the processed mature miRNA to AGO2 to form miRNPs. In
cell extract treated with gp63, we also found reduced associa-
tion of AGO2 with full-length DICER1, resulting in decreased
pre-miR-122 processing (Figure 5J). Therefore, L. donovani
targets DICER1 to prevent active miRNP formation.st & Microbe 13, 277–288, March 13, 2013 ª2013 Elsevier Inc. 283
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Figure 5. L. donovani Downregulates DICER1 and Prevents miRNP Formation in Huh7 Cells
(A) L. donovani increases pre-miR-122 levels in livers of L donovani-infected animals. RNA isolated from the livers of BALB/c mice after 15, 30, or 60 days infected
were subjected to real-time analysis, and b-actin mRNA levels were used for normalization. n = 6 for each group.
(B) pre-miR-122 levels in Huh7 cells before and after treatment with L. donovani promastigotes for 24 hr. Real-time quantification for pre-miR-122was performed.
SDs were from three independent measurements.
(C) Association of miR-122 with AGO2 in Huh7 cells interacted with L. donovani. RNA was isolated from immunoprecipitated (IP) materials from normal and
infected cell lysates, and miR-122 levels were quantified by real-time quantification and normalized against immunoprecipitated AGO2. Quantification data are
the mean values obtained from three IP reactions. Western blot was used to detect AGO2 in immunoprecipitated materials.
(D) Dicer1 levels in Leishmania-infected animal livers. Protein extracts were prepared from normal and infected mouse livers (15 or 60 days p.i.) and western
blotted for Dicer1. Huh7 cells treated with L. donovani also showed reduction in DICER1 levels.
(E) Exogenous expression of DICER1 inhibits L. donovani-mediated inhibition of miR-122 activity in Huh7 cells. Cells expressing RL reporters were transfected
with plasmids encoding FLAG-DICER1, FLAG-HA-AGO2, or GFP, and the effects of L. donovani on miR-122 activity was scored. DICER1 overexpression was
confirmed by western blot.
(F) Unlike pmiR-122 overexpressed cells, cells transfected with miR-122 mimics can escape L. donovani-mediated repression of miR-122 activity. miR-122
repressive activity was measured in normal and L.donovani-interacting Huh7 cells expressing pre-miR-122 or miR-122 mimic.
(G) DICER1 can be specifically cleaved by the Zn-metalloprotease present in the SLAs. Huh7 extracts were incubated with SLA in the presence and absence of
Zn-chelator for 30 or 60 min at 37C and were western blotted for HA-DICER1, AGO2, and DGCR8. b-actin was used as loading control.
(H) L. donovani surface protease gp63 cleaves DICER1 and generates two fragments in vitro. Lysates of HEK293T cells expressing NHA-DICER1 were incubated
with an increasing concentration of purified gp63 in the absence and presence of Zn-chelator, and cleaved product was visualized by western blot using an
HA-specific antibody. It detected a shortened DICER1 band that was 180 KDa after cleavage of full-length protein by gp63. Digestion of FLAG-DICER1 also
generated a 180 KDa fragment (marked by *). The N-terminal and short C-terminal half (marked by an arrowhead) of DICER1 were both detected with a DICER1-
specific antibody.
(I) Treatment with specific polyclonal and/or monoclonal antibody modify gp63 activity in vitro. Blocking of gp63 with a polyclonal antibody raised against the
recombinant protein reduces DICER1 cleavage activity. Anti-GRP78 antibody was used as control (upper panel). Pretreatment of gp63 against a monoclonal
(legend continued on next page)
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Leishmania donovani Reduces miR-122 in Mouse LiverRestoration of Dicer1 Expression in Parasite-Infected
Livers Rescues miR-122 Expression and Reduces Liver
Parasite Burden
When expressed exogenously, NHA-DICER1 expression was
found to be low in L. donovani-infected mouse livers (Figure 6A).
This observation was consistent with the prediction of Dicer1 as
a target that L.donovani degrades to downregulate miR-122 in
infected mouse liver. With infection, the level of gp63 was
increased in mouse livers (Figure 6B). To confirm that gp63 can
downregulate Dicer1 in vivo, purified gp63 from L. donovani
extract was entrapped in liposomes before being delivered to
Huh7 cells. Interestingly, a substantial decrease in miR-122
activity was noted in cells receiving gp63-containing liposomes
(Figure 6C). These liposomes were found to be more enriched
in mouse livers 24 hr after in vivo delivery (Figure S5A) and were
subsequently used for in vivo administration of gp63 in BALB/c
mice expressing NHA-DICER1. Delivery of gp63 to liver was
confirmed by western blot (Figure 6D). Interestingly, the level of
NHA-DICER1was significantly low in the livers of animals treated
with gp63-containing liposomes (Figure 6E). During infection,
exosomes may be the vehicles for gp63 transfer to hepatocytes
(Figures S3 and S4C). Delivery of purified L. donovani exosomes
downregulated DICER1 in animal livers (Figure 6F).
To see whether DICER1 overexpression can clear L. donovani
from infected mouse liver, we administered NHA-DICER1-
expressing plasmids (Figure 6G). Excess Dicer1 in liver
increased liver miR-122 expression and restored the serum
cholesterol level (Figures 6H and 6I). This was accompanied
with a drastic reduction in liver parasite load (Figure 6J). Impor-
tantly, no apparent change in liver cell morphology, tissue integ-
rity, or production of serum albumin was documented (Figures
S5B and S5C).
DISCUSSION
In L. donovani-infected mouse liver, almost 20% of the total
genes showed an altered expression. Several genes of choles-
terol metabolism that are indirect targets and reciprocally regu-
lated by miR-122 (Elme´n et al., 2008) were downregulated along
with miR-122 in L. donovani-infected liver. Animals manipulated
to have excess miR-122 levels in their livers showed resistance
to L. donovani infection (Figures S2B–S2E). This observation
further supports the existence of a balance of liver miR-122
and serum cholesterol that get influenced and exploited by
Leishmania parasites in infected mammals. Therapy against VL
is still a big challenge, and recently, the emergence of drug
resistance has added to the problem (Croft et al., 2006). Overex-
pressing miR-122 in infected liver tissue showed appreciable
clearance of hepatic parasite burden with a recovery of serum
cholesterol. Therefore, the therapeutic potential of miR-122
alone and in combination with cholesterol can open up avenues
to combat this deadly disease.antibody augments its activity in DICER1 cleavage assay (lower panel). Anti-GFP
product increased in the presence of anti-gp63 monoclonal antibody.
(J) The cleavage of AGO2-associated NHA-DICER1 by gp63 and its effect on pr
and transfected with NHA-DICER1 were digested with purified gp63 and subsequ
DICER1 was detected by western blot, and pre-miR-122 processing activities a
pre-miR-122 substrate; # denotes the mature miR-122 formed; WB, western blo
Cell HoL. donovani infection inmice shows a decrease in liver DICER1
expression accompanied by a concomitant increase of its
substrate pre-miR-122. Pre-let-7a RNA also showed similar
accumulation in infected mouse livers (data not shown). There-
fore, this might be a general mechanism for Leishmania to lower
the activities of miRNAs in the host cell. Interestingly, L. donovani
infection also leads to the lowering of Dicer1 and let-7a miRNA in
infected mouse macrophages (J.G., Y. Chakraborty, and S.N.B.,
unpublished data).
Inactivation of specific miRNA by virus-encoded target RNAs
or virus-encoded miRNA binding proteins in virus infected cells
has been reported previously (Belair et al., 2011; Cazalla et al.,
2010; Libri et al., 2012). Here, we report a leishmanial protease
gp63 that targets Dicer1 to reduce miRNA activity in hepatic
cells. But how the gp63, produced by the Ku¨pffer cell resident
parasites, gets transferred to the neighboring target hepato-
cytes is an unsolved issue. The Leishmania exosomes may
act as the vehicles for transport of gp63 cargo to the hepato-
cytes in mouse liver. This idea was supported by downregula-
tion of DICER1 expression in liver upon exposure to Leishmania
exosomes (Figure 6F). Interestingly, mammalian macrophages
are also known to secrete exosomes and microvesicles that
are used for intracellular transport and signal communication
(Bhatnagar et al., 2007). Therefore, it may be possible that
parasite-released gp63 get trapped within the exosomes
secreted by the host cells and get delivered to hepatocytes
to target Dicer1 and reduce miRNA activity. Immunofluores-
cence detection of gp63 in infected livers was suggestive of
propagation of this protease through the intercellular spaces
in L.donovani-infected livers.
Overall, the present study deals with an interesting connection
between altered lipid metabolism during L. donovani infection
and liver miR-122 levels. We report an alteration of a miRNA in
a parasite-infected tissue that can account for an important
metabolic change necessary for pathogenesis. This also docu-
ments a unique strategy that the parasite evolved to combat
regulatory RNA function in host cells. With human hepatic cells,
we have shown that leishmanial metalloprotease gp63 targets
DICER1 in human hepatic cells to reduce miR-122 activity.
A similar mechanism is operative for downregulation of miRNA
activity in L. donovani-infected mouse liver. It will be interesting
to investigate whether other members of the Trypanosomatidae
family have evolved a similar mechanism for their survival in in-
fected host.
EXPERIMENTAL PROCEDURES
Infection Delivery and Postinfection Analysis
L. donovani strain AG83 (MAOM/IN/1083/AG83) was used to infect 4- to
6-week old BALB/c mice with 2nd passage promastigotes or amastigotes
(107 parasites/animal) by the intracardiac route. After stipulated days of
infection, blood serum was collected and liver extract was used for RNA
or protein analysis. Liver sections were used for histological examination,antibody was used as control. The arrowhead denotes a secondary cleaved
e-miRNA processing. Extracts of HEK293 stably expressing FLAG-HA-AGO2
ently FLAG-HA-AGO2 was immunoprecipitated. FLAG-HA-AGO2-associated
ssociated with immunoprecipitated materials were quantified. ** denotes the
t. Data represent mean ± SEM. See also Figure S4.
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Figure 6. Restoration of Dicer1 Expression Rescues Serum Cholesterol Levels and Lowers Hepatic Parasite Load in L.donovani-Infected
Mouse Livers
(A) Dicer1 expression in L. donovani-infected mouse liver. Expression of NHA-DICER1 in the livers of control or infected (30 days p.i.) L. donovani BALB/c mice
three days postinjection of NHA-DICER1 expression plasmid through tail vein.
(B) Increase of gp63 in infected mouse liver extracts western blotted for gp63.
(C) Effects of liposomal delivery of gp63 onmiR-122 activity in Huh7 cells. Liposomal formulations with or without purified gp63 were delivered to cells expressing
miR-122 reporter, and fold repression was calculated.
(D) Treatment with gp63-containing liposomes delivers the protein to animal liver. Western blot detection of gp63 was done in liver lysates from control and
liposome-treated animals using an anti-gp63 antisera.
(E)Effectofgp63-containing liposomeson liverDICER1.AdultBALB/cmicewere injectedfirstwithNHA-DICER1-expressingplasmidsand thenwith liposomes (100ml
liposome suspension with or without 100 mg of purified gp63). Liver lysates were prepared after 24 hr of liposome injection and western blotted for NHA-DICER1.
(F) Effect of L. donovani exosome treatment on the mouse liver DICER1 level. Adult BALB/c mice expressing NHA-DICER1 protein were injected through the
intracardiac path with L. donovani exosomes secreted by 53 107 parasites. After 24 hr of exosome treatment, liver lysates were prepared and western blotted for
the NHA-DICER1.
(G) Expression of NHA-DICER1 increases cellular Dicer levels in mouse livers. Schematic representation of protocol of NHA-DICER1 expression in BALB/c mice
livers (upper panel). Endogeneous Dicer1 levels in both normal and NHA-DICER1 expression-plasmid-injected mouse livers after 3 days of plasmid injection
(Lower panel).
(H–J) NHA-DICER1 can prevent infection progression in mice. L. donovani-infected animals were injected with NHA-DICER1 expression plasmids and sacrificed
as per the schedule in (G). Relative miR-122 expression (H), serum cholesterol level (I), and hepatic parasite load (J) were compared between NHA-DICER1
plasmids injected and control groups. For all experiments, n was either 4 or 6, and representative western blots were shown. For all western blot experiments
b-actin was used as loading control. Data represent mean ± SEM. ***p < 0.0001, **p < 0.001, *p < 0.01. See also Figure S5.
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stained tissue imprints. Leishman-Donovan unit (LDU) = number of amasti-
gotes/1,000 nucleated cells 3 weight of spleen or liver (g).
All animal experiments approved by the institutional animal ethics
committee were carried out following the national guidelines set by the
government of India.286 Cell Host & Microbe 13, 277–288, March 13, 2013 ª2013 ElsevieParasite Transformation, Amastigote Isolation, Culture Supernatant
Collection, and Soluble Leishmanial Antigen Preparation
Amastigotes were isolated from L. donovani-infected golden hamsters. They
were either used directly or transformed to promastigotes and maintained
until the second to fourth passage cultures before the promastigotes were
used. Culture supernatants used for in vitro assays were collected fromr Inc.
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Leishmania donovani Reduces miR-122 in Mouse Livercultures grown at 22C and 37C. Soluble leishmanial antigen (SLA) was
prepared after sonication of the promastigotes as described elsewhere
(Saha et al., 1991).
Whole-Genome Microarray Analysis
Microarray analysis was done on an Illumina Sentrix Chip (Mouse WG-6 v2.0
Beadchip) using total RNA isolated from normal mouse livers and L.donovani-
infected mouse liver after 60 days. TCGA Catalyzing Genomics (New Delhi,
India) performed the analysis, and the data were analyzed after background
noise correction and normalization. Differential expression analysis was
done using Illumina custom algorithm. All the data have been filtered based
on detection; differential p value % 0.05. The whole microarray data have
been uploaded in Gene Expression Omnibus database (accession number
GSE38985).
Exogenous Expression of miR-122 and Dicer in Mouse Liver
Exogenous expression studies were conducted according to a published
hydrodynamic injection strategy (Tada et al., 2006; Andrianaivo et al., 2004).
To overexpress miR-122 or NHA-DICER1 in mouse livers, pmiR-122, the
pre-miR-122 expression plasmid, or the pCIneoNHA-DICER1 plasmid was in-
jected through the tail vein of mice at a dose of 25 mg plasmid DNA dissolved in
100 ml saline. Animals weighing 20–25 gwere used and sacrificed at 1, 3, 5, and
7 days postinjection to determine liver miR-122 levels. For NHA-DICER1
expression examination, animals were sacrificed after 3 days. In experimental
animals, injections were delivered to L. donovani-infected mice in three indi-
vidual doses starting from 15 days p.i. at intervals of 6 days. Mock plasmid-
treated (100 ml each) animals were kept as sham-treated controls. Animals
were sacrificed at 30 days p.i. along with the control group of animals, and
serum lipid profile, liver parasite burden, and miR-122 expression levels
were determined.
Cell Culture, Transfection, Treatment, and Luciferase Assays
Huh7 cells were cultured, and all transfections were performed using
Lipofectamine 2000 (Invitrogen) following manufacturer’s instructions. Renilla
luciferase (RL) and firefly luciferase (FL) activities were measured using a Dual-
Luciferase Assay Kit (Promega) measured on a VICTOR X3 Plate Reader
system (PerkinElmer), and fold repression was calculated.
Northern and Western Blot Analyses
Total RNA isolated from mouse liver was electrophoresed in 15% denaturing
TBE-Urea polyacrylamide gel and transferred to Immobilon-NY+ transfer
membrane. It was probed with 50 end 32P-labeled oligonucleotide probes
against hsa-miR-122 at 37C for 16 hr in a hybridization oven. Phosphoimag-
ing was performed with a Cyclone Plus Storage Phosphor System
(PerkinElmer). Liver tissue proteins were extracted in RIPA buffer, separated
using SDS-PAGE, transferred to polyvinylidene fluoride (PVDF) membrane,
and western blotted for different proteins using specific antibodies. b-actin
was used as a loading control. gp63 was detected in liposome-treated mouse
livers by western blot against antisera to gp63.
Real-Time Quantitative RT-PCR
The miR-122, miR-16, and U6 levels were quantified with a real-time RT-PCR
detection assay kit (Applied Biosystems) from total RNA following the manu-
facturer’s instructions. mRNA and pre-miRNA quantifications were done using
the SYBR Green Real-Time PCR Assay Kit (Invitrogen). The results were
normalized against 18S ribosomal RNA (rRNA) for mRNAs and against b-actin
for pre-miR-122.
Exosome Isolation and Treatment
Stationary-phaseL. donovanipromastigote or amastigote (5.03107 cells/ml)
culture was kept at 37C overnight. As a control, M199 medium supplemented
with 10% fetal calf serum (FCS), but without the parasites, was used.
Exosomes were isolated as described earlier (Raposo et al., 1996) with minor
modifications. For further treatment, exosomes (100 mg protein per assay)
were incubated for 1 hr at room temperature with o-Phenanthrolin or 4C over-
night with anti-gp63 antibody before the exosomes (treated or untreated) were
used in subsequent assays with Huh7 cells.Cell HoImmunoprecipitation
For immunoprecipitation (IP) reactions, HA-AGO2-transfected cells were lysed
and incubated with anti-HA (Roche) bound protein G agarose beads overnight
at 4C. As control, anti-GFP bound protein G agarose beads (Invitrogen) were
used. After that, the beads were washed thrice with IP buffer, and the bound
proteins were analyzed by western blot. Half of the beads separated during
washing steps were used for RNA extraction.
In Vitro DICER1 Cleavage Assay
For in vitro cleavage assay, NHA-DICER1 expressing Huh7 cell extract was
incubated with L. donovani SLA or purified gp63 in buffer containing 10 mM
Tris-HCl (pH 7.5), 1mM DTT, 100 mM KCl, and 13 protease inhibitor cocktail.
Incubation was done at 37C for 30 or 60 min. The reactions were stopped
with SDS sample buffer. For the o-Phenanthrolin treatment, SLA was
preincubated with 10 mM o-Phenanthrolin for 30 min on ice before being
used for the assay. For testing the purity of isolated gp63, a mouse mono-
clonal and a polyclonal anti-gp63 antibody were used to block gp63 activity
at 1:10 and 1:25 dilutions overnight. Anti-GFP and anti-GRP78 were used at
the same dilutions as the control. The samples were run in 8% SDS-PAGE,
and western blot was performed using anti-HA antibody to detect NHA-
DICER1.
In Vitro Pre-miRNA Processing Assay
The NHA-DICER1 expressing HEK293 cell lysate was incubated with purified
gp63 followed by immunoprecipitation with anti-FLAGM2 affinity gel. Washed
beads were used for pre-miR122 processing assay with 10 nM pre-miR122,
and the products were analyzed on a 12% denaturing (8 M Urea) polyacryl-
amide gel and visualized in a phosphoimager.
Introduction of Liposomes and L. donovani Exosomes in BALB/c
Mice
Adult BALB/c mice were injected with NHA-DICER1-expressing plasmids via
tail vein. After 2 days, liposomal formulations or leishmanial exosomes were in-
jected through the intracardiac route. After 24 hr, mice were sacrificed, liver
lysates were prepared, and exogenous DICER1 levels were detected by
western blot analysis using anti-HA antibody. For liposome treatment of
Huh7 cells, luciferase reporter transfected cells were treated with 200 ml lipo-
some suspension.
Other Experimental Procedures and Details
Additional experimental procedures and other essential details on plasmids,
oligos, and antibodies used have been provided as Supplemental Experi-
mental Procedures.ACCESSION NUMBERS
The Gene Expression Omnibus (GEO) accession number for the whole-
genome microarray expression data reported in this paper is GSE38985.SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, three tables, one movie, and
Supplemental Experimental Procedures and can be found with this article on-
line at http://dx.doi.org/10.1016/j.chom.2013.02.005.
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